A Phase 1 interventional study of leramistat 40mg and Itraconazole 200 mg in Pharmacokinetics, sponsored by Modern Biosciences Ltd. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-09.
Sponsored by Modern Biosciences Ltd · Phase 1, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
A DDI study consisting of 4 parts conducted as an open label, fixed sequence study in healthy adult subjects.
Modern Biosciences Ltd is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Principal Inclusion Criteria:
Healthy, adult, male or female of non 18 to 55 years of age.
Principal Exclusion Criteria:
History or presence of medical or psychiatric condition or disease in the opinion of the PI or designee.
History of any illness that, in the opinion of the PI or designee, might confound the results of the study or poses an additional risk to the subject by their participation in the study.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: leramistat 40mg · Drug: Itraconazole 200 mg
Drug: leramistat 40mg · Drug: Phenytoin 100 Mg Oral Capsule
Drug: leramistat 40mg · Drug: Simvastatin 40mg
Drug: leramistat 40mg · Drug: Upadacitinib 15 MG
Oral capsule
Oral capsule
Oral capsule
Oral capsule
Oral Capsule
leramistat: Area under the curve - AUC0-t
Time frame: 8.5 Weeks
leramistat: Area under the curve - AUC0-24h
Time frame: 8.5 Weeks
leramistat: Area under the curve - AUC0-inf
Time frame: 8.5 weeks
leramistat: Maximum observed concentration - Cmax
Time frame: 8.5 weeks
leramistat: Time of the maximum observed concentration - Tmax
Time frame: 8.5 weeks
leramistat:Elimination rate constant -Kel
Time frame: 8.5 weeks
leramistat: Half life - t½
Time frame: 8.5 weeks
leramistat: Plasma Clearance -CL/F
Time frame: 8.5 weeks
leramistat: Volume of distribution - Vz/F
Time frame: 8.5 weeks
Incidence of adverse event.
Time frame: 8.5 weeks
Plan to share: No
No publications or documents are linked to this record.
Started Apr 2024 (actual). Primary completion is estimated for Sep 2024, 5 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Leramistat · Simvastatin · Upadacitinib
Modern Biosciences Ltd